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were examined using the immunohistocemistry of the mouse limb
cartilage. Cell proliferation was assessed by PCNA staining. For gain-
and loss-of-function analyses, genes or the speciﬁc siRNAs were
overexpressed in ATDC5 cells with stable retroviral transfection or
in primary chondrocytes with adenoviral transfection. Transcriptional
regulation was examined by luciferase assay using ATDC5 and non-
chondrogenic HeLa cells transfected with a reporter construct containing
a promoter fragment of the differentiation marker genes above.
Transactivity of b-catenin was determined by the TOPﬂash system.
Computational predictions were performed using the online resource
NetworKIN for in vivo kinase-substrate relationships, and the GEO
database for expressions in the growth plate cartilage.
Results: Both isoforms were largely unphosphorylated and active in
the early differentiation stages of chondrocytes in cultured ATDC5
cells and in the mouse limb cartilage. Although Gsk3a−/− mice and
Gsk3b+/− mice showed normal skeletal development, their compound
Gsk3a−/−;Gsk3b+/− mice exhibited dwarﬁsm with impairment of early
chondrocyte differentiation without affecting the later differentiation
or proliferation. Gain- and loss-of-function analyses using cultures
of ATDC5 cells and primary chondrocytes from the knockout mice
with overexpression of GSK-3 isoforms and their siRNAs revealed
that GSK-3a and GSK-3b induced early chondrocyte differentiation
with functional redundancy in a cell-autonomous fashion. This was
independent of the canonical Wnt signaling, since the transcriptional
activity of b-catenin was not altered by the Gsk3 genotypes. Instead,
computational predictions followed by SOX9 and COL2A1 promoter assays
identiﬁed RelA (NF-úB p65) as a key phosphorylation target of GSK-3.
Further analyses by mutagenesis in the 12 putative phosphorylation
sites of RelA revealed that the Thr254-phosphorylation was essential for
GSK-3 to induce chondrocyte differentiation. The Cre-mediated deletion
of RelA in the Relaﬂ/ﬂ chondrocyte culture caused suppression of the early
differentiation markers, which was restored by the RelA overexpression,
but not by the Thr254 mutant or the GSK-3 overexpression. Lastly,
we created conditional knockout mice of Rela in undifferentiated limb
mesenchyme (Prx1-Cre;Relaﬂ/ﬂ) and in cartilage (Col2a1-Cre;Relaﬂ/ﬂ), and
conﬁrmed that both mouse models exhibited dwarﬁsm with impairment
of early chondrocyte differentiation, similar to the Gsk3a−/−;Gsk3b+/−
mice.
Conclusions: This study is the ﬁrst to show in vivo evidence of
the functional relationship of GSK-3a and GSK-3b through analysis of
compound knockout mice. Redundant functions of the two isoforms
through phosphorylation of RelA at Thr254 play a crucial role in early
stages of chondrocyte differentiation.
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THE TRANSCRIPTIONAL REGULATION OF MMP13 BY CPG
METHYLATION IN HUMAN CHONDROCYTES: HIF2-ALPHA IS A
POTENTIAL TARGET
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Purpose: In osteoarthritis (OA), articular chondrocytes undergo
phenotypic change and acquire the ability to over-express matrix-
degrading genes. We previously showed that DNA methylation at CpG
sites in the relevant promoters is correlated with the aberrant expression
of several genes, includingMMP13. However, how CpGmethylation status
intervenes to determine the promoter activity of genes such as MMP13
is still not known. The aims of the study were to determine (1) whether
CpG methylation directly affects MMP13 promoter activities, (2) which
CpG sites are responsible for changes in MMP13 promoter responses and
(3) what transcription factors are involved in CpG methylation-related
promoter regulation of MMP13.
Methods: The methylation status of the MMP13 proximal promoter and
the MMP13 gene expression were quantiﬁed in healthy and OA human
primary chondrocytes by pyrosequencing and RT-qPCR, respectively.
Three MMP13 reporter constructs, spanning −372/+14, −214/+14 and
−86/+14 bp of the proximal human MMP13 promoter were generated
by PCR-ampliﬁcation and cloned into a CpG-free luciferase reporter
vector. CpG-mutant constructs were generated by substituting CG to TG
using the wild-type −214/+14 MMP13 construct as template. Luciferase
activities were quantiﬁed for each reporter construct, untreated or
treated with DNA methyltransferase (M.SssI), and transfected in human
immortalized C28/I2 chondrocytes, alone or in co-transfection with
expression vectors encoding HIF1-alpha, HIF2-alpha, ESE1, cFos, cJun,
Runx2, USF1, GATA1 or Sp1. Chromatin immunoprecipitation (ChIP)
assays were performed in C28/I2 cells in co-transfection experiments
utilizing non-methylated or methylated MMP13 constructs, and HIF2-
alpha expression vectors, and analyzed by qPCR utilizing speciﬁc PCR
primers for the transiently transfected MMP13 constructs.
Results: The aberrant MMP13 gene expression in human primary
OA chondrocytes (25-fold higher compared to non-OA chondrocytes)
correlated with increased DNA demethylation of the MMP13 proximal
promoter, with the CpG site at −110 bp showing the greater percentage
of demethylation from the seven CpG sites contained within the −330/−14
bp proximal sequence. Luciferase assays revealed that methylation of the
wild-type MMP13 reporter constructs lead to a signiﬁcant decrease on
their basal activities. Mutation of different proximal CpG sites indicated
that only the mutation at the −110bp-CpG was able to repress the
basal activity of the non-methylated MMP13 promoter. In agreement,
the MMP13 promoter activity was preserved in a mutant construct
in which all the proximal CpG sites except for −110bp were mutated,
and methylation treatment repressed the activity of the same reporter
construct.. Over-expression of different transcription factors indicated
that only the HIF2-alpha-driven MMP13 transactivation was affected by
CpG methylation at −110bp, correlating with the decreased HIF2-alpha
binding to the methylated MMP13 proximal promoter in ChIP assays.
Conclusions: We here show that CpG methylation directly represses
the MMP13 promoter activity in vitro, and that the methylation status
of the −110bp CpG site is critical for the promoter activity, leading to
its decreased basal and HIF2-alpha-driven activity, and reducing the
binding of HIF2-alpha to the proximal promoter. The latter indicates that
HIF2-alpha shows less afﬁnity to its methylated DNA binding site, and
suggests that HIF2-alpha is likely to be a potential target of epigenetic
transcriptional regulation of MMP13.
Fig. 1. CpG methylation alters the HIF2-alpha-driven MMP13 promoter
transactivation. (a) Single CpG mutation. (b) Triple CpG mutation leaving
only one CpG intact (*p< 0.05; **p < 0.01; ***p < 0.001).
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Purpose: There is an increasing body of evidence that inﬂammatory
T cells from the synovium have a major role in the progression of
osteoarthritis by overproduction of cytokines and growth factors. The
balance between inﬂammatory and regulatory T cells is considered
to play an important role in this process. Mesenchymal stromal cells
have been extensively investigated for their tissue regeneration potential
through the last two decades. More recently, interest has partially focused
on immunogenic properties of MSC, and their abilities to regulate T-cell
and especially regulatory T-cell (Treg) function. However, their role
in regulation of immunity in arthritic diseases, most importantly in
osteoarthritis, remains mostly unknown. The purpose of this study was
to determine the inﬂuence of mesenchymal stromal cells (MSC) from
osteoarthritis (OA) patients on regulation and recruitment of regulatory
T-cells.
Methods: Bone marrow (BM) and synovial membrane (SM) was
harvested from OA patients during total hip arthroplasty (n = 19).
MSC were isolated from BM and SM and cultured in DMEM-LG
until P2. Functional analysis and immunophenotyping conﬁrmed the
presence of typical MSC markers. Mixed lymphocyte cultures enriched
in CD4+CD25+CD127− regulatory T-cells (Treg+MLC) were derived from
whole blood taken from healthy donors. Treg+MLC and MSC were
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cocultured for ﬁve days and after separation analysed for the presence
of typical MSC markers and Treg markers by FACS. Single MSC and
Treg+MLC cultures were used as controls. IL-2, 4, 6, 10, 17a, IFN-g and
TNF were assessed after 2 and 5d of cocultivation by cytometric bead
array (CBA) analysis.
In a second step, Treg+MLC cultures were analyzed in the presence of
IL-6-complemented media with varying concentrations and media taken
from MSC cultures (DMEM-LG). The abundance of IL-6 in these culture
conditions was veriﬁed at different time points by CBA analysis.
Results: Both MSC from BM and SMwere able to maintain the percentage
of Tregs in coculture, while in Treg+MLC without addition of MSC, there
was a signiﬁcant decrease of the Treg fraction after 5 days. The effect of
Treg maintenance was independent from Treg/MSC ratio. Compared to
MSC cultures alone, T-cell-MSC cocultures showed a signiﬁcant increase
in IL-6 abundance after 2 and 5 days of culture. Cocultivation with MSC
taken from synovial membrane showed signiﬁcantly higher amounts of
IL-6 production compared to BM-MSC-T-cell cocultures. Cultured without
T-cells, SM-derived MSC showed a higher IL-6 production than BM-
MSC. Overall IL-6 production was signiﬁcantly reduced after 5 days of
coculture, compared to the amounts observed at day 2. However, the
differences between SM- and BM-MSC remained signiﬁcant.
The effect of Treg maintenance could be replicated by IL-6 addition to
culture media in a dose-dependent way. However, Treg maintenance was
highest with media taken from MSC cultures, even if the abundance of
IL-6 found in these media was surmounted in naive DMEM-LG. IL-2, 4,
10, 17a, IFN-g and TNF-concentrations showed no signiﬁcant differences
between these groups.
Conclusions: The immunogenic potential of MSC has already induced
certain therapeutic approaches in autoimmune diseases. Despite the
knowledge that MSC are potent regulators of T-cell function in various
diseases, their role in the modulation of osteoarthritis is mostly
unknown. It is known that MSC can regulate and recruit Tregs in vitro.
Our data clearly demonstrates that maintenance of Treg phenotype
in MSC-T-cell cocultures can be mediated by MSC derived from
osteoarthritis patients. IL-6 seems to play an important role in mediating
these processes. However, other soluble factors secreted by MSC can be
supposed to regulate T-cell and Treg function more speciﬁcally. We
postulate that synovial inﬂammation is responsible for the signiﬁcant
differences in IL-6 secretion by MSC derived from synovial membrane
and bone marrow. However, this does not seem to affect MSC potency
to maintain the Treg phenoytype.
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MORE INFLAMMATORY SIGNS ON ULTRASOUND IN
INTERPHALANGEAL JOINTS IN EROSIVE HAND OSTEOARTHRITIS
M. Kortekaas, W-Y. Kwok, M. Reijnierse, T. Huizinga, M. Kloppenburg.
Leiden Univ. Med. Ctr., Leiden, Netherlands
Purpose: Erosive hand osteoarthritis (EOA) is a subset of hand
osteoarthritis (HOA) associated with a higher clinical burden than non-
erosive disease. The processes that lead to erosive evolution are still
unknown. The clinical course of EOA is characterised by episodes of
inﬂammatory signs, as assessed during physical examination. Recent
ultrasound (US) studies demonstrated a high incidence of inﬂammatory
signs in both HOA and EOA.
In the present study the presence of inﬂammatory signs assessed by US
in erosive and non-erosive interphalangeal joints in patients with EOA
in comparison to interphalangeal joints from patients with non-erosive
HOA was investigated.
Methods: Of 55 consecutive HOA patients, fulﬁlling the ACR criteria,
at least 45 years of age, interphalangeal joints from both hands were
studied. Conventional radiographs of both hands were scored according
to Verbruggen and Veys; E(rosive) and R(emodeled)-phases were deﬁned
as erosive. Using US all 18 interphalangeal hand joints were scored for
synovial thickening, effusion, greyscale (GS) synovitis, and Power Doppler
Signal (PDS) on a four-point scale.
Generalized estimated equation (GEE) analyses were performed to
study the association between inﬂammatory signs and erosiveness in
individual joints. GEE was also performed to study the association
between the N(ormal), S(tationary), J(oint space loss), E and R-phases
and US inﬂammatory signs. Relative risks were presented as odds ratios
(OR) with 95% conﬁdence intervals (95% CI). In multivariate analyses
adjustments were made for confounders (age, sex and BMI).
Results: Of 55 HOA patients (mean age 61 years, 86% females) 51%
showed at least one erosive joint. In 94 erosive joints GS synovitis,
synovial thickening, effusion and PDS were found in 57%, 13% 50% and
15%, respectively; in 896 non-erosive joints in 29%, 10%, 26% and 8%,
respectively. Summated scores of PDS, GS synovitis and effusion were
higher in EOA than in non-erosive HOA. GS synovitis was more frequent
in S, J, E and R-phases compared to N-phases. PDS was only associated
with E-phase (5.3 (1.3–20.5)) not with other phases. Non-erosive joints in
EOA demonstrated more PDS (3.2 (1.6–6.4)), GS synovitis (2.2 (1.3–3.7))
and effusion (2.2 (1.2–3.8)) in comparison to joints in non-erosive HOA.
Conclusions: Inﬂammatory signs are more frequent in EOA than
in non-erosive HOA, especially in the erosive joints. Remarkably,
also interphalangeal joints without erosions in patients with EOA
demonstrated more inﬂammatory US signs in comparison to
interphalangeal joints of patients with non-erosive HOA. These results
suggest an underlying systemic cause for erosive evolution.
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THE ASSOCIATION OF PERIPHERAL AND CENTRAL SENSITIZATION
WITH MUSCLE CO-ACTIVATION: A COMMON MECHANISM AFFECTING
PAIN AND FUNCTION IN KNEE OA?
T. Neogi1, J. Scholz2, J. Niu1, D. Felson1, N. Segal3, C. Woolf4,
L. Arendt-Nielsen5, M. Nevitt6, L. Bradley7, L. Frey-Law3, for The MOST
Group. 1BUSM, Boston, MA, USA USA; 2Columbia, New York, NY USA; 3Iowa,
Iowa City, IA, USA; 4Children’s Hosp., Boston, MA, USA; 5Aalborg Univ.,
Aalborg, Denmark; 6UCSF, San Francisco, CA, USA; 7UAB, Birmingham, AL,
USA
Purpose: Deep somatic pain decreases agonist and increases antagonist
activity during dynamic muscle activity (pain adaptation theory).
Muscle co-activation (antagonistic hamstring muscle activation during
quadriceps agonist activity) is of interest in knee OA because it may
increase joint stability on the one hand, but may contribute to worsening
structural lesions on the other. Experimental pain studies support central
mechanisms affecting muscle function, but whether this occurs in OA is
not known. This is relevant because knee OA is associated with peripheral
and central sensitization (nervous system alterations in pain signaling),
which in turn is associated with pain severity, but its association with
motor function changes is not known. We therefore examined whether
sensitization is associated with altered motor activity in knee OA as
assessed by muscle co-activation.
Methods: The MOST Study is a NIH-funded cohort of persons with or
at risk of knee OA. We obtained surface EMG of the medial and lateral
quadriceps and hamstrings during knee extension and ﬂexion maximum
voluntary contractions (MVC) using an isokinetic dynamometer (Cybex)
at 60°/s. Hamstring muscle co-activation was deﬁned as the median
of 4 trials in a single limb of hamstring muscle EMG activity during
knee extension MVC, standardized by the peak hamstring EMG levels
during knee ﬂexion MVC (% of max). Medial and lateral hamstring
muscles were considered separately and combined as overall hamstring
co-activation (using a root mean square approach) as our outcomes. Our
two sensitization exposures were assessed in the same limb as hamstring
co-activation: (1) Temporal summation (augmented pain response to
repetitive mechanical stimuli; a marker of central sensitization) was
deﬁned as being present when, after touching the skin over the patella
with a 60 g monoﬁlament repeatedly at 1Hz for 30 s, the subject
reported new or increased pain at the patella. (2) Pressure pain threshold
(PPT) is a marker of peripheral +/− central sensitization at sites of
disease/inﬂammation, or of central sensitization when assessed at an
otherwise normal area. PPT was assessed with an algometer (1 cm2
tip) at the patella as the point at which the participants indicated
that the pressure ﬁrst changed to slight pain. The average of 3 trials
was used to calculate the PPT. Because muscle co-activation was not
normally distributed, we categorized it into age- and sex-speciﬁc tertiles
to evaluate the relation between sensitization and muscle coactivation
with a generalized logistic model.
Results: 1633 participants had data from the surface EMG and
sensitization assessments (mean age 67.3±7.7, mean BMI 30.3±5.6, 58%
female, 39% with tibiofemoral OA). Temporal summation was present in
40%. The median (IQR) for PPT was 4.9 (3.6–6.6) kg/cm2, and for overall
hamstring co-activation was 10.1% (5.7–15.1). Temporal summation was
associated with ~30% greater odds of having the highest tertile of medial
and overall hamstring co-activation compared with the lowest tertile, but
not with lateral hamstring co-activation (Table). Low PPT (lowest tertile)
